Results 61 to 70 of about 2,139 (156)

One gene but different proteins and diseases: the complexity of dystonin and bullous pemphigoid antigen 1. [PDF]

, 2016
Since the immunochemical identification of the bullous pemphigoid antigen 230 (BP230) as one of the major target autoantigens of bullous pemphigoid (BP) in 1981, our understanding of this protein has significantly increased.
Kseniia Künzli, Luca Borradori, Borradori, Luca, Künzli, Kseniia, Chofflon, Michel, Michel Chofflon, Favre, Bertrand, Bertrand Favre   +7 more
core   +2 more sources

Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective

JEADV Clinical Practice, Volume 5, Issue 2, Page 402-414, June 2026.
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek, Iris Zalaudek, Karolina Zarańska, Bożena Cybulska‐Stopa   +3 more
wiley   +1 more source

Alterations in Type I Hemidesmosome Components Suggestive of Epigenetic Control in the Salivary Glands of Patients With Sjögren’s Syndrome [PDF]

, 2011
Artículo de publicación ISIObjective. Acinar cells in the salivary glands of patients with Sjo¨gren’s syndrome (SS) display severe alterations in anchorage to the basal lamina.
Hermoso Ramello, Marcela, Claudio Molina, Leyton, Cecilia, Alliende, Cecilia, Cecilia Alliende, Cecilia Leyton, Leyton Martínez, Cecilia, González Burgos, María Julieta, Mónica Brito, Romo, Rafael, Ewert, Patricia, María-Julieta González, Marcela Hermoso, González, Sergio, Quest, Andrew F. G., Herrera, Luisa, Aguilera, Sergio, Brito, Mónica, Paola Pérez, Quest, Andrew F.G., Pérez, Paola, Sergio González, Ulises Urzúa, González, María Julieta, Urzúa Tobar, Ulises, Sergio Aguilera, Herrera Cisterna, Luisa, Urzúa, Ulises, Hermoso, Marcela, Luisa Herrera, Patricia Ewert, Molina, Claudio, Rafael Romo, Andrew F. G. Quest   +33 more
core   +1 more source

Detection of Diagnostic Antibodies in Immune‐Mediated Diseases: A Focus on Antigens and Technologies

ChemBioChem, Volume 27, Issue 9, 14 May 2026.
This review explores autoantibody detection in immune‐mediated diseases, highlighting autoantigens including post‐translational modifications. We compared enzyme‐linked immunosorbent assay and indirect immunofluorescence with automated chemiluminescence platforms.
Silvia Bracci, Feliciana Real‐Fernandez, Federico Pratesi, Francesca Nuti, Paolo Rovero, Anna Maria Papini   +5 more
wiley   +1 more source

Demonstration of Epitope Spreading in Bullous Pemphigoid: Results of a Prospective Multicenter Study [PDF]

, 2011
Di Zenzo and colleagues have undertaken a multicenter prospective study to clarify the epitope profile for IgG anti-BP180 and BP230 antibodies in 35 patients with bullous pemphigoid (BP).
Dainichi, Teruki, Norito Ishii, Tsuruta, Daisuke, Takahiro Hamada, Minao Furumura, Daisuke Tsuruta, Hamada, Takahiro, Takashi Hashimoto, Hashimoto, Takashi, Furumura, Minao, Teruki Dainichi, Ishii, Norito   +11 more
core   +1 more source

Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid

, 2023
Bullous pemphigoid (BP) is a chronic subepidermal immunobullous disorder. Studies have demonstrated the presence of antibasement membrane zone antibodies (BP180 & BP230) in the blister fluid using enzyme-linked immunosorbent assay (ELISA).
Harish Nagarajan, Reena Rai, Krishnaswamy Mahadevan, Appalaraju Boppe   +3 more
core   +1 more source

Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 2, Page 186-198, April 2026.
Skin adverse events (AEs) frequently accompany all types of anticancer treatments. This publication discusses how recent international guidance on best‐practices use of dermocosmetics can be adapted to the North Asia region (China, Hong Kong, Japan, Republic of Korea, and Taiwan).
Meng Pan, Jianguo Sun, Makoto Kawashima, You Chan Kim, Mison Chun, Chia‐Yu Chu, Yi‐Hsin Liang, Mee Chang, Delphine Kerob, Brigitte Dreno   +9 more
wiley   +1 more source

Brein en blaren: een bijzondere band

Tijdschrift voor Gerontologie en Geriatrie
Bulleus pemphigoid (BP) is een dermatologische auto-immuun ziekte die zich kenmerkt door jeuk en blaren. Soms wordt jarenlang jeuk en een eczemateus huidbeeld gezien voorafgaand aan het ontstaan van blaren, waardoor BP niet altijd tijdig herkend wordt ...
Floor Lijten, Amée Wolters, Rianne Esselink, Satish Lubeek   +3 more
doaj   +1 more source

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 472-479, April 2026.
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche, Nina van Beek, Christoph M. Hammers, Artem Vorobyev, Michael Kasperkiewicz, Nina Schumacher, Philip Muck, Enno Schmidt   +7 more
wiley   +1 more source

Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate filaments is mediated by distinct sequences within their COOH terminus

, 2003
The bullous pemphigoid antigen 1 (BP230) and desmoplakin (DP) are members of the plakin protein family of cytolinkers. Despite their homology, their COOH termini selectively bind distinct intermediate filaments (IFs).
Favre, B., Green, K. J., Fontao, L., Fontao, Lionel, Saurat, Jean-Hilaire, Jaunin, F., Borradori, L., Green, Kathleen J., Jaunin, Fabienne, Borradori, Luca, Geerts, D., Green, Kathleen J, Riou, S., Favre, Bertrand, Sonnenberg, A., Riou, Sara, Geerts, Dirk, Sonnenberg, Arnoud, Saurat, J. H.   +18 more
core   +1 more source